Systemic autoimmune myopathies: A prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2.

Samuel Katsuyuki ShinjoFernando H C de SouzaIsabela B P BorgesAlexandre M Dos SantosRenata MiossiRafael G MisseAna C Medeiros-RibeiroCarla G S SaadEmily F N YukiSandra G PasotoLéonard V K KupaCarina CenevivaJúlia C SeraphimTatiana N PedrosaMargarete B G VendraminiClóvis A SilvaNádia E AikawaEloisa Bonfá

Published in: Rheumatology (Oxford, England) (2021)

#NCT04754698.

Keyphrases

sars cov
respiratory syndrome coronavirus
multiple sclerosis
open label
drug induced
study protocol
double blind
randomized controlled trial
disease virus